NCT00937937 2026-03-20Dinaciclib in Treating Patients With Stage IV MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting72 enrolled 14 charts
NCT01096342 2014-06-18Dinaciclib in Treating Patients With Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 6 charts